Bespoke Extracts, Inc. (OTCQB: BSPK), a Colorado-based company in the regulated cannabis market, reported its financial results for the first quarter ended March 31, 2025. The company experienced a slight increase in sales, with revenues rising to $263,159, up 1.0% from $260,428 in Q1 2024. The growth was driven by strong direct sales of branded pre-rolled joints and expanded joint production services for licensed dispensaries in Colorado. Despite the sales increase, Bespoke Extracts reported a net loss of $260,521 for Q1 2025, an improvement from the net loss of $314,118 in Q1 2024. The company also highlighted a strategic rebranding of its product offerings under The Joint Company. Looking ahead, Bespoke Extracts provided an optimistic outlook for the second quarter of 2025. Based on preliminary sales data, the company projects revenues exceeding $385,000 for the quarter ending June 30, 2025, compared to $278,163 in Q2 2024. This forecasted growth is attributed to the continued demand for its new product lines, including FreshJoints, Doobskis, and Dutch Blunts, as well as expanded third-party processing services. Additionally, improvements in manufacturing processes are expected to support higher production volumes and consistent product quality.